Hims & Hers Health, Inc. (NYSE:HIMS) is in the spotlight Monday as the company prepares to report fourth-quarter earnings after the market closes.
Fourth-Quarter Expectations, Recent Performance And What To Watch
Hims is expected to report earnings per share of 5 cents and revenue of $619.22 million. The company has topped revenue and earnings estimates in three of the last four quarters. In its most recent quarter, reported Nov. 3, Hims posted earnings per share of 9 cents, missing the 10-cent estimate, while revenue of $598.98 million beat expectations of $580.24 million.
Investors should closely monitor user growth metrics, particularly the increase in active subscriptions, as this will be crucial for validating the effectiveness of the Eucalyptus acquisition. Additionally, watch for trends in customer retention rates, which have been pivotal in driving revenue growth in previous quarters, and any shifts in the average revenue per user (ARPU) that could signal changes in consumer behavior.
“Looking ahead, we’re excited to be in a position to confidently invest in the long-term trajectory of our business. The breadth of opportunities available to us is expanding, and paired with a strong balance sheet and our team’s track record of execution, we continue to build conviction in our ability to exceed the ambitious 2030 targets we established earlier this year,” said Yemi Okupe, CFO, in the company’s third-quarter earnings report.
Hims Stock Remains Flat
HIMS Price Action: At the time of writing, Hims shares are trading 2.11% higher at $15.96, according to data from Benzinga Pro.
Image via Shutterstock
